Radiation treatment research study for adults with non-small cell lung cancer

IRB/UVA Tracking #
21718
Principal Investigator
Krishni Wijesooriya
Contact
Songserea Wood
Contact Phone
434.243.0008
Official Trial Title
A pilot randomized study of lymphocyte depletion and change in lymphocyte functionality during lung stereotactic body radiation therapy (SBRT) treatment by selectively reducing irradiation of circulating blood compared to standard of care control group
Study Description

The Department of Radiation Oncology seeks adults ages 18 and older with early stage non-small cell lung cancer (NSCLC) for a research study. The purpose of the study is to predict and reduce the immune cell reduction following lung SBRT treatments beyond standard of care treatment.

You may be eligible for this study if you have been diagnosed with early stage NSCLC and plan on receiving radiation therapy for definitive treatment and have not/ will not receive other cancer treatments within 6 months.

This study involves receiving 5 doses of Stereotactic Body Radiation Therapy (SBRT) with either an optimized treatment plan or standard treatment plan selected at random. Blood samples will be collected from participants at various time points during treatment and follow up visits. Clinic follow ups will occur 1 month, 6 months and annually after radiation treatment.
Study-related blood draws will be completed at no cost.

Compensation

$50 for completing all assessments from enrollment to 1 month follow up.